Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
10.21
+0.29 (2.92%)
At close: Mar 9, 2026, 4:00 PM EDT
10.20
-0.01 (-0.10%)
After-hours: Mar 9, 2026, 5:29 PM EDT
Biohaven Employees
Biohaven had 256 employees as of December 31, 2024. The number of employees increased by 17 or 7.11% compared to the previous year.
Employees
256
Change (1Y)
17
Growth (1Y)
7.11%
Revenue / Employee
n/a
Profits / Employee
-$2,886,023
Market Cap
1.54B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 256 | 17 | 7.11% |
| Dec 31, 2023 | 239 | 37 | 18.32% |
| Dec 31, 2022 | 202 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 291 |
| Capricor Therapeutics | 160 |
| Monte Rosa Therapeutics | 147 |
| Kodiak Sciences | 123 |
BHVN News
- 7 days ago - Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 2 months ago - Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 - PRNewsWire
- 2 months ago - US Stocks Mixed; Biohaven Shares Fall - Benzinga
- 2 months ago - Cautiously Bullish After Biohaven's Cash Runway And Dilution Risk Rise - Seeking Alpha
- 2 months ago - Biohaven Misses The Mark In Depression Trial, Stock Falls - Benzinga
- 2 months ago - Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus - Benzinga
- 2 months ago - Biohaven's depression drug fails mid-stage trial, shares fall - Reuters